Carvedilol Immediate-Release (IR) (Nested RCT subset): Clinical Trials

1 trial of Carvedilol Immediate-Release (IR) (Nested RCT subset), newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 not yet recruiting. 1 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable1Not yet recruiting 1

Follow Carvedilol Immediate-Release (IR) (Nested RCT subset): new trials by email Literature Review of Carvedilol Immediate-Release (IR) (Nested RCT subset) trials Research Report on Carvedilol Immediate-Release (IR) (Nested RCT subset)

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Comparison of the Incidence of Major Cardiovascular Events Between the Combination of Percutaneous Intervention and Optimal Drug Therapy and the Optimal Drug Therapy Alone in Patients With Chronic Coronary Syndrome
percutaneous coronary intervention, Guideline-directed Optimal Medical treatment, Carvedilol Sustained-Release (SR) (Nested RCT subset) - Chronic Coronary Syndrome
Not applicableNot yet recruitingSeoul National University Hospital23012026-06-152026-06-12

Sponsors

Seoul National University Hospital (1)

Countries

South Korea (1)